Managements fiduciary role is to get long term sp growth. Clearly that hasn't happened when compared with a year ago however in terms of looking ahead management aren't going to put out PRs just to boost the short term sp. If they believe peer review will be relevatively soon they will wait for the peer review publication. If people sell coz they are worried before the publication that would be tough luck on them but it isn't managements responsibility to massage investors short term concerns or worries about the share price variability. Only time a company might care about short term sp would be if they wanted to sell shares for more company cash but Anavex has a decent amount of cash and no debt.